Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Determining the immunohistochemical expression of GLUT1 in renal cell carcinoma using the HSCORE method (CROSBI ID 315035)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Ogorevc, Marin ; Strikic, Ante ; Zekic Tomas, Sandra Determining the immunohistochemical expression of GLUT1 in renal cell carcinoma using the HSCORE method // Biomedical reports, 15 (2021), 4; 79-79. doi: 10.3892/br.2021.1455

Podaci o odgovornosti

Ogorevc, Marin ; Strikic, Ante ; Zekic Tomas, Sandra

engleski

Determining the immunohistochemical expression of GLUT1 in renal cell carcinoma using the HSCORE method

The aim of the present study was to compare the immunohistochemical expression of glucose transporter 1 (GLUT1) between the most common histological types of renal cell carcinoma (RCC), and to determine whether a correlation between GLUT1 expression and nuclear grade or tumor size exists. A total of 19 RCC samples were selected for the study, consisting of 8 clear cell (cc)RCC and 11 non-ccRCC tissues. Immunohistochemistry for GLUT1 was performed on formalin-fixed and paraffin-embedded sections using GLUT1 antibodies. All data analyses were performed using the MedCalc software. There was a higher immunohistochemical expression of GLUT1 in the ccRCC group compared with the non-cc group, but there was no difference in GLUT1 expression between groups of RCCs with differing nuclear grades. No significant correlation between GLUT1 expression and tumor size was found. The higher immunohistochemical expression of GLUT1 in ccRCC may be a contributing factor to the clinical characteristics and behavior of that group of carcinomas. These results suggest that GLUT1 expression cannot be used as a prognostic factor for RCC, but it may be used as a predictive factor in the future.

GLUT1 ; glucose/metabolism ; immunohistochemistry ; kidney neoplasms ; renal cell carcinoma/metabolism.

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

15 (4)

2021.

79-79

objavljeno

2049-9434

2049-9442

10.3892/br.2021.1455

Povezanost rada

Kliničke medicinske znanosti, Temeljne medicinske znanosti

Poveznice
Indeksiranost